GLP-1 Users Are Spending More on Fitness and Less on Snacks and Restaurants
The gap runs to nearly four to one by one survey's count, but the shift is concentrated among affluent users and may not outlast their prescriptions.

Photo: Wendell Stoyer / Pexels
A new consumer report says the people taking weight-loss drugs like Ozempic and Wegovy are rerouting real money into fitness, buying gym memberships, personal training, supplements and recovery while pulling back on eating out, snacking and alcohol. The Consumer Collective, a US consumer-insights and advisory firm, put numbers to a shift analysts have tracked for two years: as appetite falls and weight comes off, spending changes with it. For an operator, investor or brand strategist watching the consumer economy, the question is not whether the shift is real but whether it lasts, or whether it is a spike concentrated among a wealthy, already-health-conscious group that fades when the prescriptions stop.
A big spending gap, from a small sample
The report, "How America Spends on Fitness," found that GLP-1 users say they spend $449 a month on fitness across categories, against $120 a month for people not taking the drugs. That figure is the one the report leads with, and it rests on a subsample of just 123 users drawn from an online survey of 500 US adults in July 2026, so it is best read as a directional finding rather than a precise market number.
This article is for members only
Become a member to unlock this article and all premium content.




